TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.
1 report, 1 independent
Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Jefferies Financial Group
American financial services company
-
MarketBeat
American personal finance blog
Related events
- TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.
- Analyst firms Jefferies and TD Cowen upgraded their ratings for Forgent Power Solutions, Inc., while MarketBeat provided consensus data.
- TD Cowen increased its target price to $3.00, while Jefferies Financial Group was involved in a rating update for Plug Power, with MarketBeat aggregating the consensus data.
- TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.
- Investment bank TD Cowen issued buy rating reports and upgraded the stock rating for Danaher, which is tracked by MarketBeat.